• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与对照受试者相比,非胰岛素依赖型糖尿病(NIDDM)患者骨骼肌中基础和胰岛素刺激的磷酸酪氨酸磷酸酶(PTPase)活性发生改变。

Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects.

作者信息

Worm D, Vinten J, Staehr P, Henriksen J E, Handberg A, Beck-Nielsen H

机构信息

Diabetes Research Centre, Odense University Hospital, Denmark.

出版信息

Diabetologia. 1996 Oct;39(10):1208-14. doi: 10.1007/BF02658508.

DOI:10.1007/BF02658508
PMID:8897009
Abstract

To measure possible changes in basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from insulin-resistant individuals, soluble and particulate muscle fractions were prepared from biopsies taken before and after a 3-h hyperinsulinaemic euglycaemic clamp in eight non-insulin-dependent diabetic (NIDDM) patients and nine control subjects. We used a sensitive sandwich-immunofluorescence assay and the human insulin receptor as the substrate. PTPase activity was expressed as percentage of dephosphorylation of phosphotyrosyl-residues in immobilized insulin receptors per 2 h incubation time per 83 micrograms and 19 micrograms muscle fraction protein (soluble and particulate fraction, respectively). In the diabetic soluble muscle fractions, the basal PTPase activity was decreased compared with that of control subjects (11.5 +/- 5.5 vs 27.5 +/- 3.3, p < 0.04, mean +/- SEM). In the particulate muscle fractions from the control subjects, PTPase activity was increased after 3 h hyperinsulinaemia (20.0 +/- 3.2 vs 30.2 +/- 3.6, p < 0.03) and in the corresponding soluble fractions PTPase activity seemed decreased (27.5 +/- 3.3 vs 19.9 +/- 5.9, NS). No effect of insulin on PTPase activity was found in NIDDM patients (25.1 +/- 4.1 vs 27.2 +/- 5.2, 11.5 +/- 5.5 vs 15.1 +/- 4.5 [particulate and soluble fractions], NS). In conclusion, we found that the basal PTPase activity in soluble muscle fractions was decreased in NIDDM patients; furthermore, insulin stimulation was unable to increase PTPase activities in the particulate fractions, as opposed to the effect of insulin in control subjects.

摘要

为了测定胰岛素抵抗个体骨骼肌中基础和胰岛素刺激的磷酸酪氨酸磷酸酶(PTPase)活性的可能变化,在8名非胰岛素依赖型糖尿病(NIDDM)患者和9名对照受试者进行3小时高胰岛素正常血糖钳夹前后,从活检组织中制备了可溶性和颗粒性肌肉组分。我们使用了一种灵敏的夹心免疫荧光测定法,并以人胰岛素受体作为底物。PTPase活性表示为每2小时孵育时间内,每83微克和19微克肌肉组分蛋白(分别为可溶性和颗粒性组分)中固定化胰岛素受体上磷酸酪氨酸残基去磷酸化的百分比。在糖尿病患者的可溶性肌肉组分中,基础PTPase活性与对照受试者相比降低(11.5±5.5对27.5±3.3,p<0.04,平均值±标准误)。在对照受试者的颗粒性肌肉组分中,高胰岛素血症3小时后PTPase活性增加(20.0±3.2对30.2±3.6,p<0.03),而在相应的可溶性组分中PTPase活性似乎降低(27.5±3.3对19.9±5.9,无显著性差异)。在NIDDM患者中未发现胰岛素对PTPase活性有影响(25.1±4.1对27.2±5.2,11.5±5.5对15.1±4.5[颗粒性和可溶性组分],无显著性差异)。总之,我们发现NIDDM患者可溶性肌肉组分中的基础PTPase活性降低;此外,与对照受试者中胰岛素的作用相反,胰岛素刺激无法增加颗粒性组分中的PTPase活性。

相似文献

1
Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects.与对照受试者相比,非胰岛素依赖型糖尿病(NIDDM)患者骨骼肌中基础和胰岛素刺激的磷酸酪氨酸磷酸酶(PTPase)活性发生改变。
Diabetologia. 1996 Oct;39(10):1208-14. doi: 10.1007/BF02658508.
2
Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence.通过延迟铕荧光测量胰岛素抵抗性Zucker大鼠骨骼肌中对胰岛素受体的磷酸酪氨酸磷酸酶(PTPase)活性降低。
Diabetologia. 1996 Feb;39(2):142-8. doi: 10.1007/BF00403956.
3
Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance.骨骼肌蛋白酪氨酸磷酸酶活性和酪氨酸磷酸酶1B蛋白含量与胰岛素作用及抵抗相关。
J Clin Invest. 1994 Mar;93(3):1156-62. doi: 10.1172/JCI117068.
4
Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.胰岛素抵抗的人类肥胖症和糖尿病患者骨骼肌蛋白酪氨酸磷酸酶活性及表达的改变。
J Clin Invest. 1997 Jul 15;100(2):449-58. doi: 10.1172/JCI119552.
5
Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin-resistant type II diabetic Goto-Kakizaki rats.胰岛素抵抗的II型糖尿病Goto-Kakizaki大鼠骨骼肌中蛋白酪氨酸磷酸酶1B的表达及活性升高。
Biochem Biophys Res Commun. 2000 Aug 11;274(3):583-9. doi: 10.1006/bbrc.2000.3188.
6
Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM.在正常血糖高胰岛素钳夹研究期间,血清胰岛素浓度升高会导致患有和未患有非胰岛素依赖型糖尿病的受试者骨骼肌中胰岛素受体激酶的类似激活。
Diabetes. 1995 Nov;44(11):1310-7. doi: 10.2337/diab.44.11.1310.
7
Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.磺脲类药物改善血糖控制后,2型糖尿病患者肌肉中糖原合酶的基因表达未改变。
Diabetologia. 1995 Oct;38(10):1230-8. doi: 10.1007/BF00422374.
8
Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans.胰岛素抵抗人群骨骼肌中蛋白质酪氨酸磷酸酶活性的异常调节。
Diabetes. 1991 Jul;40(7):939-42. doi: 10.2337/diab.40.7.939.
9
Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.胰岛素抵抗性肥胖和糖尿病基因模型中特定骨骼肌蛋白酪氨酸磷酸酶丰度增加。
Metabolism. 1995 Sep;44(9):1175-84. doi: 10.1016/0026-0495(95)90012-8.
10
Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.肝脏和外周细胞内葡萄糖代谢的多重缺陷导致了非胰岛素依赖型糖尿病的高血糖症。
Diabetologia. 1995 Mar;38(3):326-36. doi: 10.1007/BF00400638.

引用本文的文献

1
Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans.骨骼肌蛋白酪氨酸磷酸酶 1B 调节非裔美国人的胰岛素敏感性。
Diabetes. 2012 Jun;61(6):1415-22. doi: 10.2337/db11-0744. Epub 2012 Apr 3.
2
An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice.龙蒿提取物可增强 KK-A(y) 小鼠骨骼肌胰岛素受体信号转导并调节基因表达。
J Nutr Biochem. 2011 Jan;22(1):71-8. doi: 10.1016/j.jnutbio.2009.11.015. Epub 2010 May 5.
3
Current views on type 2 diabetes.

本文引用的文献

1
Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence.通过延迟铕荧光测量胰岛素抵抗性Zucker大鼠骨骼肌中对胰岛素受体的磷酸酪氨酸磷酸酶(PTPase)活性降低。
Diabetologia. 1996 Feb;39(2):142-8. doi: 10.1007/BF00403956.
2
Alteration of phosphotyrosine phosphatase activity in tissues from diabetic and pregnant rats.糖尿病和妊娠大鼠组织中磷酸酪氨酸磷酸酶活性的改变。
Endocrinology. 1993 Jan;132(1):67-74. doi: 10.1210/endo.132.1.8419148.
3
Insulin receptor dephosphorylation by phosphotyrosine phosphatases obtained from insulin-resistant obese mice.
当前对 2 型糖尿病的看法。
J Endocrinol. 2010 Jan;204(1):1-11. doi: 10.1677/JOE-09-0260. Epub 2009 Sep 21.
4
Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice.蛋白酪氨酸磷酸酶1B缺陷小鼠的能量消耗增加、肥胖减轻及组织特异性胰岛素敏感性增强。
Mol Cell Biol. 2000 Aug;20(15):5479-89. doi: 10.1128/MCB.20.15.5479-5489.2000.
5
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.胰岛素抵抗对人类肌肉中PI 3激酶和MAP激酶介导的信号传导有不同影响。
J Clin Invest. 2000 Feb;105(3):311-20. doi: 10.1172/JCI7535.
6
Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.蛋白酪氨酸磷酸酶-1B作为胰岛素信号转导的负调节因子。
Mol Cell Biochem. 1998 May;182(1-2):101-8.
7
Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.胰岛素抵抗的人类肥胖症和糖尿病患者骨骼肌蛋白酪氨酸磷酸酶活性及表达的改变。
J Clin Invest. 1997 Jul 15;100(2):449-58. doi: 10.1172/JCI119552.
从胰岛素抵抗肥胖小鼠中获得的磷酸酪氨酸磷酸酶对胰岛素受体的去磷酸化作用。
Diabetologia. 1994 Jan;37(1):56-60. doi: 10.1007/BF00428778.
4
Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance.骨骼肌蛋白酪氨酸磷酸酶活性和酪氨酸磷酸酶1B蛋白含量与胰岛素作用及抵抗相关。
J Clin Invest. 1994 Mar;93(3):1156-62. doi: 10.1172/JCI117068.
5
Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction.Syp(SH-PTP2)是生长因子刺激的有丝分裂信号转导的正向介质。
J Biol Chem. 1994 Aug 19;269(33):21244-8.
6
Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin.在3T3细胞中催化失活的Syp磷酸酶的表达可阻断胰岛素对丝裂原活化蛋白激酶的刺激。
J Biol Chem. 1994 Aug 19;269(33):21239-43.
7
Insulin receptor signaling is augmented by antisense inhibition of the protein tyrosine phosphatase LAR.胰岛素受体信号传导通过蛋白酪氨酸磷酸酶LAR的反义抑制而增强。
J Biol Chem. 1995 Feb 10;270(6):2435-8. doi: 10.1074/jbc.270.6.2435.
8
Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.受体型蛋白酪氨酸磷酸酶LAR丰度增加,导致肥胖人类受试者脂肪组织中胰岛素受体去磷酸化活性升高。
J Clin Invest. 1995 Jun;95(6):2806-12. doi: 10.1172/JCI117985.
9
Differential activities of protein tyrosine phosphatases in intact cells.
J Biol Chem. 1993 Oct 25;268(30):22456-62.
10
Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation.酪氨酸磷酸化激活磷酸酪氨酸磷酸酶。
Science. 1993 Mar 12;259(5101):1611-4. doi: 10.1126/science.7681217.